CURIS INC — Investor Relations & Filings
Curis, Inc. is a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. The company's clinical pipeline is led by emavusertib (CA-4948), a small molecule inhibitor of the IRAK4 kinase, being investigated for hematologic malignancies such as acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and non-Hodgkin lymphoma (NHL). Additional clinical-stage programs include fimepinostat, a dual inhibitor of HDAC and PI3K for MYC-altered cancers, and CA-170, an oral antagonist targeting the VISTA and PDL1 immune checkpoints. The company's portfolio also includes Erivedge, a Hedgehog pathway inhibitor approved for basal cell carcinoma and licensed to Genentech.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 4 | 2025-05-22 | English | |
| FORM 4 | 2025-05-22 | English | |
| FORM 4 | 2025-05-22 | English | |
| FORM 4 | 2025-05-22 | English | |
| 8-K | 2025-05-22 | English | |
| Regulatory Filings 2025 | 2025-05-20 | English |
Browse filings by year
23 years- 2026 21 filings
- 2025 62 filings
- 2024 40 filings
- 2023 35 filings
- 2022 44 filings
- 2021 34 filings
- 2020 41 filings
- 2019 33 filings
- 2018 45 filings
- 2017 46 filings
- 2016 49 filings
- 2015 55 filings
- 2014 34 filings
- 2013 57 filings
- 2012 48 filings
- 2011 49 filings
- 2010 40 filings
- 2009 54 filings
- 2008 50 filings
- 2007 45 filings
- 2006 45 filings
- 2005 57 filings
- 2004 38 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 11276401 | FORM 4 | 2025-05-22 | English | ||
| 11276402 | FORM 4 | 2025-05-22 | English | ||
| 11276409 | FORM 4 | 2025-05-22 | English | ||
| 11276410 | FORM 4 | 2025-05-22 | English | ||
| 11276411 | 8-K | 2025-05-22 | English | ||
| 11276412 | Regulatory Filings 2025 | 2025-05-20 | English | ||
| 11276413 | Regulatory Filings 2025 | 2025-05-15 | English | ||
| 11276417 | Major Shareholding Notification 2025 | 2025-05-15 | English | ||
| 11276418 | Regulatory Filings 2025 | 2025-05-13 | English | ||
| 11276422 | S-3 | 2025-05-06 | English | ||
| 11276420 | 10-Q | 2025-05-06 | English | ||
| 11276426 | 8-K | 2025-05-06 | English | ||
| 11276423 | FORM 4 | 2025-05-05 | English | ||
| 11276427 | FORM 3 | 2025-05-05 | English | ||
| 11276429 | Major Shareholding Notification 2025 | 2025-04-16 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CURIS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34952/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34952 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34952 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34952 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34952}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CURIS INC (id: 34952)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.